Disclosure Of Interests In Other Entities [Text Block]

Xspray Pharma - Filing #702829

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	282 065 SEK	—	—	—	—	—	—	331 015 SEK	—	—	—	—	—
Non-current assets	340 838 SEK	—	—	—	—	—	—	274 288 SEK	—	—	—	—	—
Current liabilities	29 966 SEK	—	—	—	—	—	—	19 818 SEK	—	—	—	—	—
Non-current liabilities	1 185 SEK	—	—	—	—	—	—	2 898 SEK	—	—	—	—	—
Revenue	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—	—
Profit (loss)	—	- SEK	- SEK	- SEK	96 698 SEK	96 698 SEK	52 410 SEK	—	- SEK	52 410 SEK	- SEK	- SEK	—
Comprehensive income	—	- SEK	- SEK	- SEK	96 698 SEK	96 698 SEK	52 410 SEK	—	- SEK	52 410 SEK	- SEK	- SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	- SEK	- SEK	- SEK	- SEK	- SEK	- SEK	—	- SEK	- SEK	- SEK	- SEK	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	271 881 SEK	—	—	—	—	—	—	325 598 SEK	—	—	—	—	209 872 SEK
Tax expense (income)	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—	—